Compare Raydium (RAY) vs Venom (VENOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Raydium vs Venom — how do they compare? Raydium trades at Rp11,126 (market cap Rp2,98T, Rp112,48M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Raydium is far larger — about 8742.6× Venom's market cap, and Raydium's circulating supply is 269,5M / 555M RAY (49%) versus 988,9M / 8B VENOM (13%) for Venom. Which is the better fit depends on your goals — on Pluang, investors hold Raydium for 25 Days and Venom for 24 Days on average.
| RAY | VENOM | |
|---|---|---|
Market Cap | Rp2,98T | Rp340,86M |
Volume (24h) | Rp112,48M | Rp2,89M |
Circulating Supply | 269,5M / 555M RAY (49%) | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 25 Days | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RAY is currently trading at Rp11,213 with a market cap of Rp3 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token has achieved significant milestones including surpassing Rp1 quadrillion in trading volume following major exchange listings on Robinhood and Revolut. Recent protocol developments include enabling 24/7 tokenized stock trading for the SpaceX IPO on Solana, expanding RAY's utility as a liquidity protocol.
Overall outlook remains cautious due to bearish technical indicators, though recent exchange listings and protocol innovations present growth opportunities. Key risks include high volatility near resistance levels and regulatory uncertainty around tokenized securities. Investors should monitor RSI levels and trading volume patterns for entry signals.
VENOM displays limited market activity with a modest market cap of Rp340.86M and only 13% of its maximum 8M token supply in circulation. The asset shows minimal trading volume and network activity, with an average hold time of 24 days indicating cautious investor behavior. No recent protocol updates or significant ecosystem developments have been observed, suggesting stagnant project growth.
Overall outlook remains cautious due to limited liquidity and adoption. Key opportunity lies in potential future protocol development, while major risks include extreme volatility from low market depth and regulatory uncertainty in the crypto space. Investors should monitor for any signs of renewed developer activity or exchange listings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Raydium
Raydium (RAY) is an automated market maker (AMM) and liquidity provider built on the Solana blockchain for the Serum decentralized exchange (DEX). Unlike any other AMMs, Raydium provides on-chain liquidity to a central limit orderbook meaning that funds deposited into Raydium are converted into limit orders which sit on Serum’s orderbooks.
Read more on RAY →About Venom
Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →
